Helen Of Troy’s Debt Overview
Over the past three months, shares of Helen Of Troy (NASDAQ:HELE) increased by 8.09%. Before we understand the importance of debt, let us look at how much debt Helen Of Troy has.
From Benzinga’s Global Small Cap Conference: Amryt Pharma CFO & COO, Rory Nealon Begins Presenting
https://www.youtube.com/watch?v=XkOilNZqoEI
Related Posts
Stifel Maintains Buy on MercadoLibre, Lowers Price Target to $1000
Stifel analyst Scott Devitt maintains MercadoLibre (NASDAQ:MELI) with a Buy and lowers the price target from $1200 to $1000.
MyMD Pharma Highlights New Data From Study Conducted By Eurofins Discovery Phenotypic Center Of Excellence Comparing Biological Activities Of Co.’s Lead Compound MYMD-1
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs
Company plans to initiate Phase II trial with a leading academic institution
BALTIMORE--(BUSINESS WIRE)-- MyMD
Cantor Fitzgerald Initiates Coverage On IMV with Overweight Rating, Announces Price Target of $4
Cantor Fitzgerald analyst Brandon Folkes initiates coverage on IMV (NASDAQ:IMV) with a Overweight rating and announces Price Target of $4.